Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03318978 · ClinicalTrials.gov registry record · Early Phase 1
Benzo[a]Pyrene Ultralow Dose-Response Study
A Early Phase 1 study of Environmental Exposure, sponsored by Oregon State University.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 8
- Enrollment target
- 1
- Study location
NCT03318978 is a Early Phase 1 study of Environmental Exposure that has completed, run by Oregon State University. The registered enrollment target is 8 participants, below the 290-participant average among 13 other Environmental Exposure trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03318978, a Early Phase 1 study of Environmental Exposure, has completed, sponsored by Oregon State University.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 8 participants
- Enrollment target
- 1
- Study location
Study Summary
Evaluation of the pharmacokinetics for \[14C\]-benzo\[a\]pyrene (\[14C\]-BaP) and metabolites in plasma and urine over 48 hours following 4 oral doses of 25, 50, 10 and 250 ng (2.7-27 nCi).
Conditions Studied
Interventions
- DRUG [14C]-benzo[a]pyrene
Study Locations (1)
Oregon
- Clinical Research Facility, 407 Linus Pauling Science Center, Oregon State University - Corvallis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2018-04-17 |
| Est. Completion | 2024-02-01 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03318978
The ClinicalTrials.gov registry entry for NCT03318978 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 290-participant average among 13 other Environmental Exposure trials with a reported enrollment target (97% lower). The listed sponsor is Oregon State University, which has 33 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Environmental Exposure appearing as the primary indexed condition, and to 1 intervention - of which [14C]-benzo[a]pyrene is the first listed.
NCT03318978 reports 1 study location spanning 1 distinct geographic area - top geographies include Oregon.
Frequently Asked Questions
What is clinical trial NCT03318978 about?
NCT03318978 is a clinical study titled "Benzo[a]Pyrene Ultralow Dose-Response Study". Evaluation of the pharmacokinetics for \[14C\]-benzo\[a\]pyrene (\[14C\]-BaP) and metabolites in plasma and urine over 48 hours following 4 oral doses of 25, 50, 10 and 250 ng (2.7-27 nCi).
What is the current status of trial NCT03318978?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 8 participants. The study started on 2018-04-17. Estimated completion is 2024-02-01.
What conditions does trial NCT03318978 study?
This clinical trial studies the following conditions: Environmental Exposure.
What interventions are being tested in trial NCT03318978?
The interventions under investigation include: [14C]-benzo[a]pyrene (DRUG).
Who is sponsoring clinical trial NCT03318978?
This trial is sponsored by Oregon State University, which has 33 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03318978 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Environmental Exposure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Ultralow Dose PAH Binary Mixture Study
COMPLETED · Early Phase 1
-
Assessing and Addressing Community Exposures to Environmental Contaminants
RECRUITING · NA
-
Childhood Activities Nutrition and Development Oversight
RECRUITING · NA
-
Developmental Impacts of Microplastics Exposure in Early Life
RECRUITING
-
Table-Top Water Pitcher to Reduce Arsenic Exposure Among Well Users in New Hampshire
RECRUITING · NA
-
A Personalized Biomonitoring and Report-back Intervention to Reduce Exposure to Endocrine Disrupting Chemicals
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.